News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
11 November 2024
Consistent Supporting the Independence of Domestic Health Products, Dexa Group is Committed to Developing Natural Medicines
As a national pharmaceutical company, Dexa Group plays a crucial role in supporting Indonesia's healthcare independence and resilience by providing medicines for 277.14 million patients of the Health Social Security Agency (Badan Penyelenggara Jaminan Sosial (BPJS Kesehatan)). Dexa Group highlighted this theme at the Innovation and Technology in Health Transformation…
8 November 2024
Commission IX of the Republic of Indonesia Commends Phyto-pharmaceutical Production Facility and Advocates for Inclusion of Indigenous Modern Medicines in National Health Insurance
In an effort to bolster the resilience and quality of the national pharmaceutical industry, the House of Representatives Commission IX, led by Deputy Chairperson Drg. Putih Sari conducted a targeted work visit to PT Ferron Par Pharmaceuticals, a subsidiary of Dexa Group, in Cikarang on Thursday, November 7, 2024. The…
30 October 2024
Consistently Marketing Indonesian Pharmaceutical Products in Cambodia for 25 Years, Dexa Medica Wins Primaduta Award
PT Dexa Medica, through its subsidiary Dynamic Argon Co., Ltd., has been awarded the 2024 Primaduta Award in the category of Indonesian Product Promoter. This recognition from the Government of the Republic of Indonesia honours the company's role as a distributor, consistently marketing and promoting Indonesian products in Cambodia for…
19 October 2024
Dexa Group Inaugurates the Center for Pharmaceutical and Nutraceutical Research and Policy at Atma Jaya Catholic University, Jakarta
In collaboration with the Atma Jaya Catholic University of Jakarta, Dexa Group inaugurated the Center for Pharmaceutical and Nutraceutical Research and Policy (CPNRP), a research and policy center under the Atma Jaya University Rectorate. This inauguration is part of Dexa Group's commitment to promoting innovation in the healthcare sector and…
9 October 2024
Dexa Group Strengthens Collaboration Between Government, SOEs, and the Private Sector to Achieve National Health Independence
Collaboration between the government, State-Owned Enterprises (SOEs), and the private sector in the health sector plays a crucial role in building a stronger and more equitable national health system and economy. This was the conclusion drawn by speakers at the BNI Investor Daily Summit 2024 during Plenary Session 4, titled…
3 October 2024
Integrating Technology in the Pharmaceutical Sector, Dexa Medica Achieves INDI 4.0 Award
Integrating Technology in the Pharmaceutical Sector, Dexa Medica Achieves INDI 4.0 Award The innovative efforts of PT Dexa Medica in research and technology development to produce high-quality pharmaceutical products have earned recognition from the government. PT Dexa Medica received the Indonesia Industry 4.0 Readiness Index (INDI 4.0) 2024 award from…
1 October 2024
Dexa Medica Wins Indonesia Halal Industry Award 2024 from Ministry of Industry
Dexa Group, through PT Dexa Medica, received the Indonesia Halal Industry Award (IHYA) 2024 from the Ministry of Industry (Kemenperin) in the Best Halal Supply Chain category. This award recognizes Dexa Medica's commitment to supporting Indonesia's halal industry ecosystem. The award was presented by Kemenperin’s Secretary-General, Mr. Eko SA Cahyanto,…